Navigation Links
Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation
Date:6/24/2009

St. Jude study shows personalized chemotherapy can improve cure rate and avoid the use of radiation in acute lymphoblastic leukemia treatment

MEMPHIS, Tenn., June 24 /PRNewswire-USNewswire/ -- Childhood acute lymphoblastic leukemia (ALL) can be successfully treated using a carefully personalized chemotherapy regimen without cranial radiation, investigators at St. Jude Children's Research Hospital have found. Such radiation of the brain was once a standard ALL treatment to prevent recurrence of the leukemia in the central nervous system (CNS).

Despite radiation's success in treating ALL, it produces side effects that include second cancers, stunted growth, hormone imbalances and cognitive deficits. Optimized use of anticancer drugs, especially those instilled directly into the spinal fluid, have enabled clinicians to reduce radiation use, and only patients at highest risk for relapse have received cranial radiation.

Now, St. Jude researchers have established that radiation can be safely eliminated in all patients with the use of highly effective chemotherapy regimens. The findings appear in the June 25, 2009, issue of the New England Journal of Medicine.

"Cranial radiation was an invaluable treatment when it was introduced by St. Jude oncologists in the mid-1960s," said Ching-Hon Pui, M.D., chair of the St. Jude Department of Oncology and an American Cancer Society Professor. "It controlled CNS leukemia and boosted the cure rate for ALL from only 4 percent to 50 percent. But radiation's side effects led to the steady reduction of dosages and limited use to the highest-risk patients." According to Pui, the paper's lead author, about 20 percent of the approximately 3,400 cases of childhood ALL diagnosed in the U.S. each year are still treated with radiation. In some developing countries, radiation continues to be used in the majority of children with ALL.

"Ov
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
5. Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
8. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
11. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:R...earsfollowinganautoaccident,wasactuallyfullyconsci...rningAmericasegment.TheDynaVoxEyeMaxwasfeaturedint...eandotherconditionscanunlockcommunication. ,, W...bleonlineat www.dynavoxtech.com ,, WHO:R...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Anady...thatitwillpresentatthe21stAnnualPiperJaffrayHealth...T(6:00a.m.PST).TheconferenceisbeingheldatTheNewYor...xecutiveOfficerofAnadys,willprovideanoverviewofAna...73. ,, Thecorporatepresentationwillbesimultaneo...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire/--Accumetrics,Inc...w®System,thefirstrapidandeasy-to-usediagnosti...eantiplateletagents(e.g.Plavix®andaspirin),an...cumetrics,andGregoryJ.Tibbitts,ChiefFinancialOffic...atthe21stAnnualPiperJaffrayHealthCareConferencebei...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels 60493 1Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels 60493 2Aflex Unveils Revolutionary New Hose Design for the Chemical and Process Industry 5897 1Aflex Unveils Revolutionary New Hose Design for the Chemical and Process Industry 5897 2Better Hearing Institute Urges People with Diabetes to Get Their Hearing Checked 3B Joins in Global Effort to Promote World Diabetes Day 60490 1Better Hearing Institute Urges People with Diabetes to Get Their Hearing Checked 3B Joins in Global Effort to Promote World Diabetes Day 60490 2Better Hearing Institute Urges People with Diabetes to Get Their Hearing Checked 3B Joins in Global Effort to Promote World Diabetes Day 60490 3
... at Keystone Scientific Meeting, SOUTH SAN FRANCIS...-- Rigel today announced that Yonchu,Jenkins, Ph.D...ing,on the company,s efforts to develop a small mo...n Immunodeficiency Virus (HIV),infection at the Ke... and 29th. Dr. Jenkins will present both a poster ...
...gram of Intravenous Antihypertensives,to Date Pres...ch 27, 2007 /PRNewswire-FirstCall/ -- Findings,fro...intravenous,antihypertensive therapies, show that ...a potentially harmful elevation in,blood pressure ...tients undergoing cardiac surgery is strongly asso...
Other Medicine Technology:Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 2Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 3Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 4
(Date:11/25/2009)...ving beyond the treatment of cavities and the glam...these more traditional practices in a whole new li... what the public expects form dentistry, we know t... part of the medical team. The increasingly import... strengthened every day by new and ongoing researc...
(Date:11/25/2009)...ng again commits to SAS70 Audit to demonstrate SOX...(PRWEB) November 25, 2009 -- Partners Consulting S...ration has completed the American Institute of Cer...ting Standards (SAS) No. 70 type II audit. SAS 70 ...ing the internal controls of service providers and...
(Date:11/25/2009)...asive procedures that provide patients profound re...tis, or sinus infection, are being developed and u...tute. Techniques such as balloon sinuplasty clean...emove any bone or tissue like traditional sinus s... treating sinus symptoms were featured in a recent...
(Date:11/25/2009)...DreamHealer,s GlobalIntentionHealsProjectprovedtha...eoneatadistance.Over10,000participantssenthealingi...byaquantitative-EEG.Thedatawasanalyzedbyworldexper...B.C.Adaminitiatedtheworld,slargestintentionalheali...ipofaspecificvisualizationtobeusedbyallparticipant...
(Date:11/24/2009)...o a significantly higher risk of strokes and cardi...in the British Medical Journal . , The research...ization,s Collaborating Centre for Nutrition, base...ital in Coventry, UK, and the European Society of ...ed at the Department of Clinical and Experimental ...
Breaking Medicine News(10 mins):Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 3Health News:Partners Consulting Completes SAS70 Audit 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:High salt intake linked to strokes and cardiovascular disease 2
...reatments available for incontinence nowadays, an ...n and women struggling with incontinence. The main...ent himself, by minimizing the severity of his con... best policy in helping them with their condition....
...iabetes Association , Wel...and Indian Community understands the serious heal...2 diabetes among Native Americans in the United St...rom diabetes are major causes of death and health ...
...over £28m in critical illness cover claims b...critical illness claims were declined due to non-d...cer, heart related and stroke , ...critical illness cover claims, showing that betwee...
...rchers and scientists from around the world will g...he largest and most prestigious gastroenterology m...ick Place Convention Center, Chicago, IL. DDW is t...rchers will present exciting, cutting-edge data du...
...y Discussions on Improving Access to More Affordab... 28 Teva Pharmaceuticals USA, the leading generic... series of community roundtables as part of their ...the need for access to more affordable healthcare ...
...ories, Ltd. (NYSE Amex: CPD ) recorded net sales...$350.4 million during Fiscal 2008. We earned a ne...09 compared to a net pre-tax income of $42.4 milli...50.4 million, respectively, reflecting a decrease ...
Other Medicine News:Health News:Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook 2Health News:Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook 3Health News:Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook 4Health News:Prairie Island Indian Community Supports Fight Against Diabetes Locally and Nationally 2Health News:Scottish Widows Releases Critical Illness Cover Claims Figures 2Health News:AGA Institute presents cutting-edge research during DDW 2Health News:AGA Institute presents cutting-edge research during DDW 3Health News:AGA Institute presents cutting-edge research during DDW 4Health News:The Year of Affordable Healthcare Brings Together San Francisco Community Groups to Tackle Healthcare Crisis 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection 5
S-ROM Femoral Stems - Standard Length Stems 36mm Neck with +21mm Calcar Replacement
WG-1-10xx Revision Quatroloc Femoral Stems
SL Revision
AcuMatch C-Series LONG STEM
Medicine Products: